OncoCyte Corporation Board of Directors

OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Mr. Joshua Riggs

Mr. Joshua Riggs

President, CEO & Director

Mr. Peter Hong

Mr. Peter Hong

VP, General Counsel & Secretary

Ms. Andrea Susan James

Ms. Andrea Susan James

Chief Financial Officer

Dr. Paul R. Billings FACP, M.D.

Dr. Paul R. Billings FACP, M.D.

Consulting Chief Medical Officer

Mr. Yuh-Min Chiang Ph.D.

Mr. Yuh-Min Chiang Ph.D.

Chief Technology Officer

Mr. James Liu

Mr. James Liu

Senior Director, Controller & Principal Accounting Officer

Dr. Michael D. West Ph.D.

Dr. Michael D. West Ph.D.

Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.

Ms. Sandra O'Donald

Ms. Sandra O'Donald

Senior Vice President of Business Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.